Acute erythraemic myelosis is a rare condition first defined by Di Guglielmo in 1923 as 'an autonomous pathologic entity, ie, a primary and specific disease characterized by a generalized proliferation of the erythropoietic cells of the bone marrow, analogous to the leucocytic proliferation in leukaemia'.
Although Di Guglielmo emphasized the 'purity' of the erythroblastic proliferation, Baldini, Fudenberg, Fukutake, and Dameshek (1959) considered this form to be extremely rare and that mixed forms showing proliferation of both erythroblastic and myeloblastic elements were more common. They suggested that the natural history of the disorder may pass through several phases. In the first, erythroid hyperplasia predominates giving the picture of erythraemic myelosis as described by Di Guglielmo; in the second, dual erythroblastic and myeloblastic proliferation produces erythroleukaemia which may proceed in the final phase to predominant myeloblastic proliferation. Several cases have terminated, however, as myelomonocytic leukaemia (Hindmarsh and Wickham, 1955; Sheets, Drevets, and Hamilton, 1963) . In regarding erythraemic myelosis and erythroleukaemia as transitory stages in the same pathological entity, Dameshek and Baldini (1958) FIRST ADMISSION A 65-year-old woman was admitted to hospital on 15 June 1966, because of increasing tiredness for one year with loss of weight, progressive breathlessness, and paraesthesiae of the hands and feet for six months. Clinical examination showed pallor of the mucosae with a slight lemon tinge of the skin but no apparent conjunctival icterus. The tongue was smooth and atrophic. The pulse was 108 per minute and blood pressure 150/50 mm/Hg. The heart was not enlarged. A loud ejection systolic murmur was audible in all areas and transmitted into the neck vessels. There were no signs of congestive cardiac failure and the chest was clinically and radiologically normal. The liver edge was felt two fingerbreadths below the right subcostal margin and although the spleen was not clinically palpable, a radiograph of the abdomen revealed significant splenic enlargement. There was no palpable lymphadenopathy. Examination of the central nervous system, including the optic fundi, was normal.
Laboratory investigations Haemoglobin was 4-1 g per 100 ml; PCV 114%; MCHC 35-5%; reticulocytes, 3%; WBC 3,100 per cu mm, with a normal differential count. The blood film showed anisopoikilocytosis with macrocytosis, erythroblastaemia (6 nucleated red cells per 100 white cells) and blue polychromasia. Neutrophils showed nuclear hypersegmentation and occasional giant metamyelocytes were seen. Platelets were adequate.
Sternal marrow examination showed marked erythroblastic hyperplasia with excessive mitotic activity (Fig. 1 ). There was a marked shift to the left in the erythroid cells, the majority being proerythroblasts and basophilic megaloblasts. Many of these immature cells contained 2 to 4 nuclei and many showed prominent cytoplasmic and nuclear vacuolation. Repeat examination of the sternal marrow showed extreme hypercellularity due to proliferation of erythroblasts, pro-erythroblasts, and haemocytoblasts, many of these cells again showing prominent cytoplasmic and nuclear vacuolation with a tendency for the cytoplasm to 'bud' and fragment. Many also contained multiple nuclei and there was now little or no maturation beyond the erythroblast stage. An unusual feature was the phagocytosis by reticulum cells of erythroblasts, mature erythrocytes, and shed cytoplasmic fragments. Normal marrow elements were almost entirely replaced by the malignant transformation of the erythroid precursors. Periodic-acid-Schiff staining showed positive granules within many of the erythroblasts (Hayhoe, Quaglino, and Flemans, 1960) . The morphological appearances of this repeat marrow examination confirmed the original suspicion of Di Guglielmo's disease.
Serum folate was 2-7 m,ug per ml, and liver function tests showed thymol turbidity, I unit; alkaline phosphatase, 5 units; cephalin cholesterol, negative; serum bilirubin, 0 5 mg per 100 ml; SGOT 90 units; SGPT 40 units; one-stage prothrombin time was 20 seconds (control 15 seconds); serum albumin and globulin, 3-6 and 2-6 gper 100 ml respectively; serum urea, 49 mg per 100 ml; serum electrolytes, normal.
A radioactive B12 absorption test using the hepatic uptake method (Glass, Boyd, Gellin, and Stephanson, 1954) showed a low vitamin B,2 uptake which was corrected by intrinsic factor.
The results of these further investigations and thX haematological relapse occurring while the patient was still receiving vitamin B12 indicated the coexistence of Di Guglielmo's disease and pernicious anaemia, an apparently unique combination of disease entities and one presenting special difficulties in management. The use of antimetabolites seemed justified (see discussion) and treatment with pyrimethamine, 25 mg daily, together with Aneurine compound tablets was started. Transfusion of packed cells from five bottles of blood was also given after which peripheral blood examination showed Hb 10gper 100 ml; PCV 35 5%; MCHC 28-5%; WBC 2,400 per cu mm. On the tenth day of treatment with pyrimethamine she developed a small epistaxis and blood examination showed a significant thrombocytopenia. The pyrimethamine was stopped and the bleeding tendency controlled by prednisone, 5 mg qid. Five days later she was discharged for two weeks' convalescence.
FINAL ADMISSION On her final admission she was pyrexial and clinical examination showed further enlargement of the liver and spleen and a few bruises were now present over both legs. Examination of the peripheral blood showed Hb 7-3 g per 100 ml; PCV 22%; MCHC 33 %; WBC 4,200 per cu mm. In the film macrocytosis and an occasional erythroblast were present. No immature white cells were seen. Platelets were virtually absent. After a further transfusion, the patient developed a widespread petechial rash and had repeated epistaxes and haematemeses. She developed terminal bronchopneumonia and died on 25 September just 14 weeks from the date of her first admission.
NECROPSY REPORT (Dr I. B. Porteous) The main macroscopic changes were widespread ecchymoses of the arms and legs, multiple petechial haemorrhages of the gastric mucosa, bilateral bronchopneumonia, and extension of red marrow throughout the whole length of both femora. The cut surfaces of the enlarged liver (2,100 g) and spleen (250 g) showed congestive changes.
The relevant microscopic features were confined to the liver, spleen, and bone marrow. Liver sections showed centrilobular congestion with clumps of primitive erythroblasts and haemocytoblasts within the dilated sinuses. The spleen showed complete loss of its follicular architecture with marked reticuloendothelial hyperplasia and reticulin overgrowth, distension of the sinusoids by proliferating haemocytoblasts and erythroblasts, and focal haemorrhages predominantly subcapsular. Sections of the marrow showed no changes additional to those observed from aspirates obtained during life.
DISCUSSION
In this patient just described, all the criteria for the diagnosis of Addisonian pernicious anaemia appear to have been fulfilled apart from the atypical bone marrow features and the negative intrinsic factor antibody test which is, however, positive in only 570% of cases (Ardeman and Chanarin, 1963 Peripheral blood This commonly shows a normochromic macrocytic anaemia with anisopoikilocytosis and a varying degree of erythroblastaemia, and a normal, decreased or slightly increased white cell count with occasional to frequent immature myeloid cells and usually thrombocytopenia.
Bone marrow The picture is that of intense erythroid hyperplasia of megaloblastic or megaloblastoid type with maturation arrest at a primitive level, increased mitotic activity with aberrant nuclear forms, and commonly replacement of myeloid and megakaryocytic elements (Fig. 1) . In most instances a variable number of the erythroblasts give a positive PAS-staining reaction Spray and Witts (1958) , Adams and Seaton (1960) , and Metz and Klein (1960) exceptions being, however, our own case and that reported by Gibson, Pollock, and Stankler (1963) . This estimation cannot, therefore, be regarded as a completely reliable means of differentiation. The finding of high serum BL2 levels led Dameshek (1958) described by Baldini et al (1959) . 'Knobby cytoplasmic projections' of erythroid precursors were also noted by Martin and Bayrd (1954) in case 1 of their series. None of these authors offered an explanation for the unusual morphological features but it seems reasonable to assume that they are degenerative in nature and a manifestation of defective cell production and development. Phagocytosis of nucleated and mature erythrocytes by reticulum cells, a feature (Fig. 3) (Goodall, Guthrie, and Buist, 1965) . The phenomenon observed in both marrow aspirates in our patient would appear to explain, in part at least, the haemolytic element commonly present in erythraemic myelosis. With no evidence to support an immune mechanism, we would further speculate that the abnormal phagocytic activity results from the reticulo-endothelial prollferation which should be regarded as an integral part of the disorder and not merely as a secondary manifestation of the production of abnormal red cells. This view gains support from the concept which regards erythraemic myelosis as a form of reticulo-endotheliosis (Di Guglielmo and Quattrin, 1942; Schwartz and Critchlow, 1952) and the fact that erythrophagocytosis commonly occurs in this group of disorders. Giant metamyelocytes and macropolycytes are myeloid changes (Fig. 4) which are usually regarded as characteristic of vitamin B12orfolic acid deficiency and are said not to occur in erythraemic myelosis (Israels, 1963) . They have previously been noted, however, in two patients (cases I and III of Schwartz and Critchlow, 1952) . In neither of these cases were serum B12 or folate levels assayed and as neither had features of pernicious anaemia it is probable that folate deficiency, analogous to that which may be found in other neoplastic or leukaemic conditions (Rose, 1965) Finally we regard the apparently unique combination oferythraemic myelosis and pernicious anaemia in our patient as being quite fortuitous. It may be pertinent to note, however, that the coexistence of the two diseases is somewhat analogous to the development of polycythaemia vera, also a myeloproliferative disorder, in a small number of cases of pernicious anaemia (Delamore, 1961; Engel and Stickney, 1962; Douglas and Rifkind, 1964) and that one such case terminated in acute leukaemia (Zarafonetis, Overman, and Molthan, 1957) . Also of possible relevance is the occurrence of acute erythraemic myelosis in a small number of patients with polycythaemia vera (Dammert and Kaipainen, 1960; Perkins, Israels, and Wilkinson, 1964; Scott, Ellison, and Ley, 1964; Watkins, Fairley, and Scott, 1967) . The paucity of communications reporting the coexistence of pernicious anaemia and myeloproliferative disorders, including erythraemic myelosis, would indicate that the combination is no more than a chance association, but a definite relationship cannot be completely excluded.
TREATMENT There is no known effective drug treatment for erythraemic myelosis and although transfusion may provide useful supportive therapy, the prognosis is poor and survival is usually measured in months.
Jn the past, the megaloblastoid appearances of the bone marrow have led to the administration of liver extract, vitamin B12, or folic acid but none has produced recognizable benefit. Their rational use should be limited to cases of proven deficiency but one may question, even in these circumstances, whether they may not accelerate the abnormal cell proliferation. Antimetabolites have provided some temporary benefit especially in the more chronic types of the disease (Sheets et al, 1963) , but their use in the acute varieties must necessarily depend on the blood and marrow status. In our patient the use of an antimetabolite was considered to be hazardous because of the marked depression of myeloid and megakaryocytic elements but as the abnormal proliferation was purely erythroblastic, pyrimethamine was considered worthy of trial as it has been shown to have a temporary inhibitory action on the red cell hyperplasia of polycythaemia vera (Isaacs, 1954; Pegg and Ford, 1961) and polycythaemia secondary to hypoxic lung disease (Pengelly, 1966) . It proved of no benefit and probably contributed to the thrombocytopenia. Later, in reviewing the literature, we discovered that pyrimethamine had been used in one previous case and although producing an arrest of maturation, led to explosive hyperplasia of extremely large proerythroid blast cells (Sheets et al, 1963) . These experiences seem to contraindicate its further use in erythraemic myelosis.
Steroids have proved of value only in controlling the haemorrhagic manifestations.
Splenectomy has been performed in several cases without beneficial effect and in some instances has been followed by a marked increase in the degree of erythroblastaemia.
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